Riten Kumar: DOACs Effectiveness in Pediatric Cancer-Associated Thrombosis
Riten Kumar, Director of Thrombosis and Anticoagulation at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, shared a post on LinkedIn, about a recent article he and his colleagues co-authored, adding:
”Direct oral anticoagulants are efficacious when appropriately used in children with cancer associated thrombosis – though the rate of clinically relevant bleeding in this cohort was higher than what’s been reported in the pediatric randomized trials……..
Most CRNM bleeds occurred in the setting of thrombocytopenia.”
Title: Safety and efficacy of direct oral anticoagulants in pediatric oncology patients: real-world data from two quaternary care pediatric centers
Authors: Riten Kumar, Emily Drake, Joseph Stanek, Nicholas Yeager, Lynda M. Vrooman, Lewis B. Silverman, Vilmarie Rodriguez
Read the Full Article on Research and Practice in Thrombosis and Haemostasis
Find more posts featuring Riten Kumar on Hemostasis Today.
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC
-
Oct 16, 2026, 12:17Exploring Endothelial Cells, Genetic Fate Mapping, and Revascularization – ISTH
-
Oct 16, 2026, 10:07Habib Bennaceur: Building a Stronger Care Pathway for Sickle Cell Disease in India
-
Oct 16, 2026, 09:59Tareq Abadl: A Simple Guide to Blood Collection Tubes
-
Oct 16, 2026, 09:50Mona Alfaraj: Distinguishing HCL from SMZL in Bone Marrow
-
Oct 16, 2026, 09:44New International Consensus on Covert Brain Infarction – International Journal of Stroke